HeraMED Limited (ASX:HMD)

HeraMED Income Statement

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	0.29	0.36	0.61	0.32	0.12
Other Revenue	0.14	0.12	-	-	-
Revenue	0.43	0.48	0.61	0.32	0.12
Revenue Growth (YoY)	-10.31%	-20.62%	88.22%	170.27%	132.67%
Cost of Revenue	0.38	-	0.24	0.12	0.06
Gross Profit	0.05	0.48	0.36	0.21	0.06
Selling, General & Admin	2.51	3.91	4.22	2.56	2.47
Research & Development	1.03	1.34	2.12	1.12	2.08
Operating Expenses	3.9	5.93	7.03	4.89	5.48
Operating Income	-3.85	-5.45	-6.67	-4.68	-5.42
Interest Expense	-0	-0.05	-0.01	-2.18	-2.19
Interest & Investment Income	0	0.01	-	-	-
Currency Exchange Gain (Loss)	-0.05	-	-0.12	-0.37	-0
Other Non Operating Income (Expenses)	0.4	-	0.03	0.06	-0.1
EBT Excluding Unusual Items	-3.5	-5.49	-6.78	-7.18	-7.72
Asset Writedown	-0.63	-	-	-	-0.13
Pretax Income	-4.13	-5.49	-6.78	-7.18	-7.85
Net Income	-4.13	-5.49	-6.78	-7.18	-7.85
Net Income to Common	-4.13	-5.49	-6.78	-7.18	-7.85
Shares Outstanding (Basic)	1,070	532	260	214	175
Shares Outstanding (Diluted)	1,070	532	260	214	175
Shares Change (YoY)	101.27%	104.14%	21.65%	22.61%	38.84%
EPS (Basic)	-0.00	-0.01	-0.03	-0.03	-0.04
EPS (Diluted)	-0.00	-0.01	-0.03	-0.03	-0.04
Free Cash Flow	-3.66	-4.81	-5.71	-3.77	-4.47
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-0.02	-0.03
Gross Margin	11.69%	100.00%	60.05%	64.24%	51.24%
Operating Margin	-891.10%	-1132.82%	-1100.13%	-1453.02%	-4545.69%
Profit Margin	-957.27%	-1140.95%	-1117.60%	-2229.48%	-6588.22%
Free Cash Flow Margin	-847.42%	-1000.44%	-942.64%	-1171.67%	-3751.19%
EBITDA	-3.82	-5.41	-6.59	-4.66	-5.41
D&A For EBITDA	0.02	0.04	0.08	0.02	0.01
EBIT	-3.85	-5.45	-6.67	-4.68	-5.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.